Immediate Impact
68 standout
Citing Papers
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Recent Progress of Supramolecular Chemotherapy Based on Host–Guest Interactions
2023 Standout
Works of Daniel Bruetman being referenced
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology
2011
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Bruetman | 314 | 457 | 46 | 60 | 15 | 520 | |
| Ritsuko Komaki | 265 | 484 | 22 | 121 | 17 | 566 | |
| Hisao Uejima | 370 | 371 | 129 | 22 | 22 | 545 | |
| Ö. Ataman | 309 | 175 | 162 | 37 | 21 | 523 | |
| Joseph M. Colasanto | 165 | 375 | 43 | 98 | 12 | 550 | |
| Armando Preatoni | 379 | 478 | 62 | 37 | 10 | 591 | |
| C. Terhaard | 257 | 378 | 51 | 59 | 20 | 557 | |
| H. Selim | 283 | 369 | 16 | 58 | 12 | 483 | |
| Yuzo Kurita | 172 | 500 | 36 | 31 | 18 | 600 | |
| Xin Sun | 172 | 329 | 108 | 53 | 28 | 493 | |
| Yenting Ngai | 268 | 376 | 76 | 59 | 17 | 544 |
All Works
Loading papers...